Your browser doesn't support javascript.
loading
Comparing Proton to Photon Radiotherapy Plans: UK Consensus Guidance for Reporting Under Uncertainty for Clinical Trials.
Lowe, M; Gosling, A; Nicholas, O; Underwood, T; Miles, E; Chang, Y-C; Amos, R A; Burnet, N G; Clark, C H; Patel, I; Tsang, Y; Sisson, N; Gulliford, S.
Afiliação
  • Lowe M; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, The University of Manchester, Manchester, UK. Electronic address: Matthew.Lowe2@christie.nhs.uk.
  • Gosling A; Department of Radiotherapy Physics, University College London Hospitals NHS Foundation Trust, London, UK.
  • Nicholas O; South West Wales Cancer Centre, Swansea Bay NHS Trust, Swansea, UK; Swansea University Medical School, Swansea University, Swansea, UK; National Radiotherapy Trials Quality Assurance Group, Velindre Cancer Centre, Cardiff, UK.
  • Underwood T; Division of Cancer Sciences, School of Medical Sciences, The University of Manchester, Manchester, UK.
  • Miles E; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Hospital, Northwood, Middlesex, UK.
  • Chang YC; Department of Radiotherapy, University College London Hospitals NHS Foundation Trust, London, UK.
  • Amos RA; Proton and Advanced Radiotherapy Group, Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
  • Burnet NG; Division of Cancer Sciences, School of Medical Sciences, The University of Manchester, Manchester, UK; The Christie NHS Foundation Trust, Manchester, UK.
  • Clark CH; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Hospital, Northwood, Middlesex, UK.
  • Patel I; Christie Medical Physics and Engineering, The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, School of Medical Sciences, The University of Manchester, Manchester, UK.
  • Tsang Y; National Radiotherapy Trials Quality Assurance Group, Mount Vernon Hospital, Northwood, Middlesex, UK.
  • Sisson N; National Radiotherapy Trials Quality Assurance Group, The Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, Wirral, UK.
  • Gulliford S; Department of Radiotherapy Physics, University College London Hospitals NHS Foundation Trust, London, UK; Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
Clin Oncol (R Coll Radiol) ; 32(7): 459-466, 2020 07.
Article em En | MEDLINE | ID: mdl-32307206

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prótons / Planejamento da Radioterapia Assistida por Computador / Neoplasias Nasofaríngeas / Ensaios Clínicos como Assunto / Guias de Prática Clínica como Assunto / Fótons / Órgãos em Risco Tipo de estudo: Etiology_studies / Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Prótons / Planejamento da Radioterapia Assistida por Computador / Neoplasias Nasofaríngeas / Ensaios Clínicos como Assunto / Guias de Prática Clínica como Assunto / Fótons / Órgãos em Risco Tipo de estudo: Etiology_studies / Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Clin Oncol (R Coll Radiol) Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article